Skip to main content

Collegium Pharmaceutical, Inc

COLL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001267565

No open-market purchases or sales by Collegium Pharmaceutical, Inc insiders were filed in the last 90 days; 287 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Collegium Pharmaceutical, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Collegium Pharmaceutical, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Collegium Pharmaceutical, Inc
NameTitleLast reported holdingLast filingFilings, past year
Santini GinoDirector112,483Jun 10, 20262
Freund John GordonDirector83,952May 20, 20262
Bohlin Garen GDirector71,000May 18, 20262
Lurker NancyDirector26,758May 18, 20262
Paya Carlos VDirector28,323May 18, 20261
Balice-Gordon Rita J.Director61,370May 18, 20262
Glancy Donovan MichaelDirector17,482May 18, 20261
Dieter DavidEVP & General Counsel68,231Apr 3, 20264
Dreyer ScottEVP & Chief Commercial Officer71,770Mar 5, 20263
Karnani VikramPresident and CEO197,864Feb 12, 20262
Smith Thomas BEVP and Chief Medical Officer90,651Feb 12, 20261
Tupper ColleenEVP & Chief Financial Officer147,282Feb 12, 20262
Fallon John A.Director64,634Nov 14, 20251
Rubric Capital Management LP10% Owner3,132,743IndirectAug 15, 20250
Rosen David Efraim10% Owner3,132,743IndirectAug 15, 20250
Kuhlmann Shirley R.EVP and General Counsel108,137Mar 6, 20250
Heffernan Michael ThomasDirector50,328Feb 12, 20250
Melincoff Gwen ADirector52,468May 16, 20240
McFarlane Neil F.Director49,365May 16, 20240
Ciaffoni JosephPresident and CEO444,867Feb 14, 20240
Malamut RichardEVP and Chief Medical Officer130,264Feb 14, 20220
Fleming Alison BEVP & Chief Technical Officer143,694Aug 12, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 20, 2026 (view filing)May 182 daysFreund John GordonDirectorSSale−20$34.05−$6810.0%84.0K after
May 18, 2026 (view filing)May 153 daysFreund John GordonDirectorSSale−4.13K$34.54−$142.5K−4.7%84.0K after
May 15, 2026 (view filing)May 132 daysLurker NancyDirectorSSale−4.50K$35.97−$161.9K−20.0%18.0K after
May 13, 2026 (view filing)May 112 daysBohlin Garen GDirectorSSale−8.70K$37.18−$323.5K−12.3%62.3K after
Mar 20, 2026 (view filing)Mar 182 daysDieter DavidEVP & General CounselSSale−14.0K$34.92−$488.0K−15.4%77.1K after10b5-1
Mar 11, 2026 (view filing)Mar 92 daysDieter DavidEVP & General CounselSSale−6.22K$36.65−$228.1K−6.4%91.0K after10b5-1
Mar 5, 2026 (view filing)Mar 32 daysDreyer ScottEVP & Chief Commercial OfficerSSale−50.0K$40.40−$2.02M−41.0%71.8K after2 lots10b5-1
Dec 10, 2025 (view filing)Dec 82 daysDreyer ScottEVP & Chief Commercial OfficerSSale−17.6K$48.17−$847.8K−14.5%103.6K after2 lots10b5-1
Dec 9, 2025 (view filing)Dec 54 daysBalice-Gordon Rita J.DirectorSSale−3.65K$47.03−$171.7K−6.5%52.6K after
Nov 14, 2025 (view filing)Nov 122 daysFallon John A.DirectorSSale−34.9K$47.21−$1.65M−35.0%64.6K after
Nov 7, 2025 (view filing)Nov 61 dayTupper ColleenEVP & Chief Financial OfficerSSale−30.0K$40.53−$1.22M−19.1%126.7K after2 lots10b5-1
Sep 3, 2025 (view filing)Aug 295 daysSmith Thomas BEVP and Chief Medical OfficerSSale−17.5K$38.42−$671.5K−19.9%70.3K after
Aug 20, 2025 (view filing)Aug 182 daysDreyer ScottEVP & Chief Commercial OfficerSSale−16.4K$38.21−$626.2K−13.7%103.6K after10b5-1
Aug 19, 2025 (view filing)Aug 154 daysSantini GinoDirectorSSale−5.41K$37.19−$201.0K−5.4%95.0K after
Aug 15, 2025 (view filing)4:12 PM ETAug 132 daysRubric Capital Management LP and 1 other10% OwnerSSaleCommon Stock, par value $0.001 per share−25.0K$37.85−$946.3K−0.8%3.13M after
Aug 15, 2025 (view filing)Aug 132 daysDreyer ScottEVP & Chief Commercial OfficerSSale−4.86K$38.03−$184.9K−4.5%103.6K after10b5-1
Aug 12, 2025 (view filing)Aug 84 daysFreund John GordonDirectorSSale−11.7K$34.36−$400.6K−33.5%23.1K after
Jun 11, 2025 (view filing)Jun 92 daysFreund John GordonDirectorSSale−6.60K$30.62−$202.1K−8.5%70.7K after
Mar 24, 2025 (view filing)Mar 20-214 daysTupper ColleenEVP & Chief Financial OfficerSSale−7.60K$30.03−$228.3K−4.6%156.7K after2 lots10b5-1
Mar 24, 2025 (view filing)Mar 20-214 daysDreyer ScottEVP & Chief Commercial OfficerSSale−20.8K$30.03−$624.8K−16.7%103.6K after2 lots10b5-1
Mar 18, 2025 (view filing)Mar 117 daysDreyer ScottEVP & Chief Commercial OfficerSSale−15.4K$30.00−$461.6K−10.8%126.7K afterAmended10b5-1
Mar 18, 2025 (view filing)Mar 144 daysTupper ColleenEVP & Chief Financial OfficerSSale−977$30.00−$29.3K−0.6%164.3K after10b5-1
Mar 18, 2025 (view filing)Mar 144 daysDreyer ScottEVP & Chief Commercial OfficerSSale−2.25K$30.00−$67.7K−1.8%124.4K after10b5-1
Mar 13, 2025 (view filing)Mar 112 daysTupper ColleenEVP & Chief Financial OfficerSSale−10.4K$30.01−$313.5K−5.9%165.2K after10b5-1
Mar 10, 2025 (view filing)Mar 6-74 daysTupper ColleenEVP & Chief Financial OfficerSSale−3.45K$30.00−$103.6K−1.9%175.7K after2 lots10b5-1
Mar 10, 2025 (view filing)Mar 6-74 daysDreyer ScottEVP & Chief Commercial OfficerSSale−5.64K$30.00−$169.3K−3.8%142.1K after2 lots10b5-1
Mar 6, 2025 (view filing)Mar 4-62 daysKuhlmann Shirley R.EVP and General CounselSSale−86.1K$28.20−$2.43M−44.3%108.1K after3 lots
Jan 14, 2025 (view filing)Jan 104 daysKuhlmann Shirley R.EVP and General CounselSSale−27.5K$33.04−$908.6K−18.7%119.2K after2 lots10b5-1
Sep 17, 2024 (view filing)Sep 134 daysSmith Thomas BEVP and Chief Medical OfficerSSale−9.59K$36.62−$351.3K−15.1%53.8K after
Sep 6, 2024 (view filing)Sep 5-61 dayKuhlmann Shirley R.EVP and General CounselSSale−20.2K$38.26−$773.8K−14.5%119.2K after3 lots
Jun 5, 2024 (view filing)Jun 32 daysKuhlmann Shirley R.EVP and General CounselSSale−25.0K$32.57−$814.2K−15.2%139.4K after2 lots10b5-1
May 29, 2024 (view filing)May 281 dayTupper ColleenEVP & Chief Financial OfficerSSale−19.7K$34.21−$674.3K−13.1%130.8K after10b5-1
May 28, 2024 (view filing)May 23-245 daysDreyer ScottEVP & Chief Commercial OfficerSSale−108.0K$33.90−$3.66M−50.5%105.9K after2 lots
May 16, 2024 (view filing)May 142 daysBohlin Garen GDirectorSSale−29.0K$32.30−$936.2K−39.3%44.8K after
Mar 4, 2024 (view filing)Feb 294 daysSmith Thomas BEVP and Chief Medical OfficerSSale−995$36.76−$36.6K−1.5%63.4K after
Feb 28, 2024 (view filing)Feb 262 daysDreyer ScottEVP & Chief Commercial OfficerSSale−10.0K$36.43−$364.3K−6.7%138.9K after2 lots10b5-1
Jan 18, 2024 (view filing)Jan 162 daysDreyer ScottEVP & Chief Commercial OfficerSSale−23.6K$32.28−$760.5K−17.5%111.3K after10b5-1
Dec 22, 2023 (view filing)Dec 211 dayCiaffoni JosephPresident and CEOSSale−4.36K$30.38−$132.4K−1.6%275.0K after10b5-1
Dec 20, 2023 (view filing)Dec 18-202 daysCiaffoni JosephPresident and CEOSSale−68.8K$30.18−$2.08M−20.0%275.0K after3 lots10b5-1
Nov 29, 2023 (view filing)Nov 272 daysKuhlmann Shirley R.EVP and General CounselSSale−25.6K$25.78−$660.0K−17.6%119.5K after10b5-1
Jun 28, 2023 (view filing)Jun 262 daysKuhlmann Shirley R.EVP and General CounselSSale−18.0K$21.72−$390.6K−13.1%119.5K after2 lots10b5-1
Jun 2, 2023 (view filing)Jun 1-21 dayCiaffoni JosephPresident and CEOSSale−62.5K$21.85−$1.37M−18.5%275.0K after3 lots10b5-1
Jun 1, 2023 (view filing)May 30-312 daysCiaffoni JosephPresident and CEOSSale−62.5K$21.88−$1.37M−15.6%337.5K after2 lots10b5-1
Mar 17, 2023 (view filing)Mar 152 daysTupper ColleenEVP & Chief Financial OfficerSSale−31.6K$23.77−$752.1K−23.1%105.4K after
Mar 3, 2023 (view filing)Mar 12 daysDreyer ScottEVP & Chief Commercial OfficerSSale−13.3K$26.70−$355.8K−9.0%134.9K after
Feb 14, 2023 (view filing)Feb 131 dayKuhlmann Shirley R.EVP and General CounselSSale−21.8K$26.88−$586.3K−13.7%137.5K after
Feb 14, 2023 (view filing)Feb 131 dayCiaffoni JosephPresident and CEOSSale−11.3K$26.88−$302.4K−2.7%400.1K after
Jan 11, 2023 (view filing)Jan 92 daysDreyer ScottEVP & Chief Commercial OfficerSSale−17.8K$27.39−$488.6K−14.8%102.8K after3 lots
Dec 27, 2022 (view filing)Dec 22-275 daysHeffernan Michael ThomasDirectorSSale−25.0K$23.58−$590.5K−47.2%28.0K after4 lots
Dec 27, 2022 (view filing)Dec 22-275 daysCiaffoni JosephPresident and CEOSSale−2.46K$23.67−$58.3K−1.0%248.8K after4 lots